PubMed:10810403 / 1302-1474 JSONTXT

Annnotations TAB JSON ListView MergeView

    c_corpus

    {"project":"c_corpus","denotations":[{"id":"T275","span":{"begin":0,"end":11},"obj":"C032690"},{"id":"T273","span":{"begin":0,"end":11},"obj":"GO:0004303"},{"id":"T274","span":{"begin":0,"end":11},"obj":"GO:0047035"},{"id":"T278","span":{"begin":8,"end":11},"obj":"PR:P35492"},{"id":"T280","span":{"begin":8,"end":11},"obj":"PR:000008437"},{"id":"T279","span":{"begin":8,"end":11},"obj":"143095"},{"id":"T281","span":{"begin":127,"end":133},"obj":"UBERON:0000310"},{"id":"T282","span":{"begin":149,"end":155},"obj":"UBERON:0000310"},{"id":"T283","span":{"begin":149,"end":165},"obj":"D001943"},{"id":"T284","span":{"begin":149,"end":165},"obj":"D001943"}],"text":"17 beta-HSD type 2 immunoreactivity was sporadically detected in non-proliferative or Ki67 negative ductal epithelia of normal breast, but rarely in breast carcinoma cells."}

    PubmedHPO

    {"project":"PubmedHPO","denotations":[{"id":"T7","span":{"begin":149,"end":165},"obj":"HP_0003002"}],"text":"17 beta-HSD type 2 immunoreactivity was sporadically detected in non-proliferative or Ki67 negative ductal epithelia of normal breast, but rarely in breast carcinoma cells."}

    UseCases_ArguminSci_Discourse

    {"project":"UseCases_ArguminSci_Discourse","denotations":[{"id":"T7","span":{"begin":0,"end":172},"obj":"DRI_Background"}],"text":"17 beta-HSD type 2 immunoreactivity was sporadically detected in non-proliferative or Ki67 negative ductal epithelia of normal breast, but rarely in breast carcinoma cells."}

    PubMed_ArguminSci

    {"project":"PubMed_ArguminSci","denotations":[{"id":"T6","span":{"begin":0,"end":172},"obj":"DRI_Background"}],"text":"17 beta-HSD type 2 immunoreactivity was sporadically detected in non-proliferative or Ki67 negative ductal epithelia of normal breast, but rarely in breast carcinoma cells."}